Study of EQ001 (Itolizumab) in Systemic Lupus Erythematosus With or Without Active Proliferative Nephritis
Public ClinicalTrials.gov record NCT04128579. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1b Multiple Ascending-dose Study of EQ001 in Subjects With Systemic Lupus Erythematosus With or Without Active Proliferative Lupus Nephritis
Study identification
- NCT ID
- NCT04128579
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Equillium
- Industry
- Enrollment
- 52 participants
Conditions and interventions
Conditions
Interventions
- Itolizumab [Bmab 600] Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2019
- Primary completion
- Nov 15, 2023
- Completion
- Jan 17, 2024
- Last update posted
- Apr 17, 2025
2019 – 2024
United States locations
- U.S. sites
- 19
- U.S. states
- 7
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| AKDHC Medical Research Services, LLC | Sun City | Arizona | 85351 | — |
| California Institute of Renal Research | Chula Vista | California | 91910 | — |
| University of California San Diego Perlman Ambulatory Clinic | La Jolla | California | 92037 | — |
| Clinical Research of West Florida - Clearwater | Clearwater | Florida | 33765-2616 | — |
| Centre for Rheumatology, Immunology and Arthritis | Fort Lauderdale | Florida | 33309 | — |
| University of Florida, Division of Rheumatology | Gainesville | Florida | 32610 | — |
| Clinical Site Partners Leesburg, LLC | Leesburg | Florida | 34748 | — |
| SouthCoast Research Center Inc | Miami | Florida | 33136 | — |
| Hope Clinical Trials | Miami | Florida | 33165 | — |
| Omega Research Maitland, LLC | Orlando | Florida | 32810 | — |
| Clinical Research of West Florida - Tampa | Tampa | Florida | 33603 | — |
| University of South Florida | Tampa | Florida | 33606 | — |
| Georgia Nephrology | Lawrenceville | Georgia | 30046 | — |
| Northwell Health / Division of Rheumatology | Great Neck | New York | 11021 | — |
| Columbia University Medical Center, Div of Nephrology | New York | New York | 10032 | — |
| Albert Einstein College of Medicine, Montefiore Medical Center | The Bronx | New York | 10461 | — |
| Northeast Clinical Research Center, LLC | Bethlehem | Pennsylvania | 18017 | — |
| Dallas Renal Group | Dallas | Texas | 75230 | — |
| Prolato Clinical Research Center (PCRC) | Houston | Texas | 77054 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04128579, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 17, 2025 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04128579 live on ClinicalTrials.gov.